Ocular adverse events associated with anti-VEGF therapy: A pharmacovigilance study of the FDA adverse event reporting system (FAERS)
Work
Year: 2022
Type: article
Abstract: Background: The purpose of this study is to identify and characterize ocular adverse events (AEs) that are significantly associated with anti-VEGF drugs for treatment of neovascular age-related macula... more
Source: Frontiers in Pharmacology
Institutions The Affiliated Yongchuan Hospital of Chongqing Medical University, Chongqing Medical University, Army Medical University, Southwest Hospital
Cites: 53
Cited by: 20
Related to: 10
FWCI: 6.195
Citation percentile (by year/subfield): 85.01
Topic: Retinal and Optic Conditions
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: gold
APC paid (est): $2,950